Intervention Review

Intermediate acting versus long acting insulin for type 1 diabetes mellitus

  1. Moshe Vardi1,*,
  2. Eyal Jacobson2,
  3. Asaph Nini3,
  4. Haim Bitterman4

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 30 SEP 2007

DOI: 10.1002/14651858.CD006297.pub2

Database Title

Additional Information

How to Cite

Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006297. DOI: 10.1002/14651858.CD006297.pub2.

Author Information

  1. 1

    Carmel Medical Center, Internal Medicine, Haifa, Israel

  2. 2

    Clalit Health Services, Haifa and Western Galilee District, Department of Family Medicine, Haifa, Israel

  3. 3

    Sheba Medical Center, Intensive Care Unit, Tel Hashomer, Israel

  4. 4

    Carmel Lady Davis Medical Center, Internal Medicine, Haifa, Israel

*Moshe Vardi, Internal Medicine, Carmel Medical Center, 7 Michal St, Haifa, Haifa, 34362, Israel. MosheVa3@clalit.org.il.

Publication History

  1. Publication Status: New
  2. Published Online: 16 JUL 2008

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (566K)Full (1788K)

  1. Current Version

    Intermediate acting versus long acting insulin for type 1 diabetes mellitus

    Moshe Vardi, Eyal Jacobson, Asaph Nini and Haim Bitterman

    Article first published online: 16 JUL 2008 | DOI: 10.1002/14651858.CD006297.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Intermediate acting versus long acting insulin for type 1 diabetes mellitus

    M Vardi and A Nini

    Article first published online: 16 APR 2008 | DOI: 10.1002/14651858.CD006297

View Full Article (HTML) Summary (59K)Standard (566K)Full (1788K)